The Relationship of Biomarkers of Heart Failure and Stress Echocardiography in the Early Post-Infarction Period
The relationship of stress echocardiography with cardiac structural parameters in the early post-infarction period in patients who underwent stenting is considered, as well as the identification of the relationship between the level of cardiac biomarkers (NTproBNP, BIN1) with the results of stress echo in this group of patients. The study included 96 patients after the first myocardial infarction and underwent coronary stenting. As a result of stress echocardiography, all patients were divided into 2 groups. The first group with a positive sample, the second group with a negative sample. It was revealed that reduced systolic function against the background of increased volume indices of the left heart was significantly associated with a positive stress echo test in patients in the early post-infarction period who underwent coronary stenting. A positive stress echo test is associated with NTproBNP values above the range of normal values. A significant increase in the BIN1 serum biomarker was determined only in the group of patients with a positive stress echo test.
Melnikova M.A., Ruzov V.I., Gimaev R.H., Egorushin Y.M., Vorobyov A.M. 2023. The Relationship of Biomarkers of Heart Failure and Stress Echocardiography in the Early Post-Infarction Period. Challenges in Modern Medicine, 46(4): 368–375 (in Russian). DOI: 10.52575/2687-0940-2023-46-4-368-375
While nobody left any comments to this publication.
You can be first.
Roger V.L. 2013. Epidemiology of heart failure. Circ Res. 113: 646–659. doi: 10.1161/circresaha.113.300268
Sulo G., Igland J., Vollset S.E., Nygard O., Ebbing M., Sulo E., Egeland G.M., Tell G.S. 2016. Heart failure complicating acute myocardial infarction; burden and timing of occurrence: a nation‐wide analysis including 86 771 patients from the cardiovascular disease in Norway (CVDNOR) project. J. Am. Heart. Assoc.5. doi: 10.1161/jaha.115.002667
Jenca D., Melenovsky V., Stehlik J., Stanek V., Kettner J., Kautzner J., Adámková V., Wohlfahrt P. 2021. Heart failure after myocardial infarction: incidence and predictors. ESC Heart Fail. 8(1): 222–237. doi: 10.1002/ehf2.13144.
Wellings J., Kostis J.B., Sargsyan D., Cabrera J., Kostis W.J. 2018. Risk factors and trends in incidence of heart failure following acute myocardial infarction. Am. J. Cardiol. 122: 1–5.doi:10.1016/j.amjcard.2018.03.005.
Carvalho L.F., Bogniotti L.C., Almeida O., E Silva J., Nadruz W., Coelho O.R., Sposito A.C. 2019. Change of BNP between admission and discharge after ST‐elevation myocardial infarction (Killip I) improves risk prediction of heart failure, death, and recurrent myocardial infarction compared to single isolated measurement in addition to the GRACE score. Eur. Heart. J. Acute. Cardiovasc. Care. 8: 643–651. doi: 10.1177/2048872617753049
Mok Y., Sang Y., Ballew S.H., Hoogeveen R.C., Ballantyne C.M., Rosamond W., Coresh J., Selvin E., Matsushita K. 2019. Premorbid levels of high‐sensitivity cardiac troponin T and natriuretic peptide and prognosis after incident myocardial infarction. Am. Heart. J. 216: 62–73. doi: 10.1016/j.ahj.2019.07.002
Felker G.M., Anstrom K.J., Adams K.F., Ezekowitz J.A., Fiuzat M., Houston-Miller N., Januzzi J.L., Mark D.B., Piña I.L., Passmore G., Whellan D.J., Yang H., Cooper L.S., Leifer E.S., Desvigne-Nickens P., O'Connor C.M. 2017. Effect of natriuretic peptide-guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: a randomized clinical trial. JAMA. 318: 713–720. doi: 10.1001/jama.2017.10565
Nikolova A.P., Hitzeman T.C., Baum R., Caldaruse A.M., Agvanian S., Xie Y., Geft D.R., Chang D.H., Moriguchi J.D., Hage A., Azarbal B., Czer L.S., Kittleson M.M., Patel J.K., Wu A.H.B., Kobashigawa J.A., Hamilton M., Hong T., Shaw R.M. 2018. Association of a novel diagnostic biomarker, the plasma cardiac bridging integrator 1 score, with heart failure with preserved ejection fraction and cardiovascular hospitalization. JAMA Cardiol. 3: 1206–1210. doi: 10.1001/jamacardio.2018.3539
Hitzeman T.C., Xie Y., Zadikany R.H., Nikolova A.P., Baum R., Caldaruse A.M., Agvanian S., Melmed G.Y., McGovern D.P.B., Geft D.R., Chang D.H., Moriguchi J.D., Hage A., Azarbal B., Czer L.S., Kittleson M.M., Patel J.K., Wu A.H.B., Kobashigawa J.A., Hamilton M., Hong T., Shaw R.M. 2020. cBIN1 Score (CS) Identifies Ambulatory HFrEF Patients and Predicts Cardiovascular Events. Front. Physiol. 11: 503. doi:10.3389/fphys.2020.00503
Fabiani I., Pugliese N.R., Santini C., Fabiani I., Pugliese N.R., Santini C., Miccoli M., D'Agostino A., Rovai I., Mazzola M., Pedrinelli R., Dini F.L. 2019. The assessment of pressure-volume relationship during exercise stress echocardiography predicts left ventricular remodeling and eccentric hypertrophy in patients with chronic heart failure. Cardiovasc Ultrasound. 17(1): 6. doi: 10.1186/s12947-019-0157-z.
Donal E., Panis V., Kosmala W. 2021. Exercise stress echocardiography: a great tool that can be adapted to the clinical question? Open Heart. 8(1). doi: 10.1136/openhrt-2021-001641.
Ahmadvazir S., Shah B.N., Zacharias K., Senior R. 2018. Senior R.Incremental prognostic value of stress echocardiography with carotid ultrasound for suspected CAD. JACC Cardiovasc Imaging. 11: 173–180. doi: 10.1016/j.jcmg.2016.12.020
Hampson R., Vamvakidou A., Kinsey C., Singh B., Senior R. 2019. Clinical effectiveness of a sonographer-led, cardiologist-interpreted stress echocardiography service in the rapid access stable chest pain clinic. Int. J. Cardiol. 281: 107–112. doi: 10.1016/j.ijcard.2019.01.080
Kusunose K. 2020. Clinical Application of Stress Echocardiography in Management of Heart Failure. Heart Failure Clinics. 16(3): 347–355. doi: 10.1016/j.hfc.2020.02.001.
Woodward W., Dockerill C., McCourt A. et al. 2022. Real-world performance and accuracy of stress echocardiography: the EVAREST observational multi-centre study. Eur. Heart. J. Cardiovasc. Imaging. 23(5): 689–698. doi: 10.1093/ehjci/jeab092.
Lang R.M., Badano L.P., Mor-Avi V., Afilalo J., Armstrong A., Ernande L., Flachskampf F.A., Foster E., Goldstein S.A., Kuznetsova T., Lancellotti P., Muraru D., Picard M.H., Rietzschel E.R., Rudski L., Spencer K.T., Tsang W., Voigt J.U. 2015. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. European Heart Journal: Cardiovascular Imaging. 16(3): 233–270. doi: 10.1016/j.echo.2014.10.003
Sicari R., Nihoyannopoulos P., Evangelista A., Kasprzak J., Lancellotti P., Poldermans D., Voigt J.U., Zamorano J.L. 2009. Stress Echocardiography Expert Consensus Statement–Executive Summary: European Association of Echocardiography (EAE) (a Registered Branch of the ESC). European Heart Journal. 30: 278–289. doi:10.1093/eurheartj/ehn492
Richards A.M. 2018. N-Terminal B-type Natriuretic Peptide in Heart Failure. Heart. Fail. Clin. 14(1): 27–39. doi: 10.1016/j.hfc.2017.08.004.
The work was carried out without external sources of funding.